jnccn.org/abstract/journals/jnccn/15/7/article-p883.xml
Preview meta tags from the jnccn.org website.
Linked Hostnames
14- 153 links tojnccn.org
- 110 links toscholar.google.com
- 80 links topubmed.ncbi.nlm.nih.gov
- 31 links towww.ncbi.nlm.nih.gov
- 2 links towww.nccn.org
- 1 link todoi.org
- 1 link toeducation.nccn.org
- 1 link tojnccn360.org
Thumbnail
Search Engine Appearance
NCCN Guidelines Insights: Antiemesis, Version 2.2017
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Antiemesis address all aspects of management for chemotherapy-induced nausea and vomiting. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for Antiemesis, specifically those regarding carboplatin, granisetron, and olanzapine.
Bing
NCCN Guidelines Insights: Antiemesis, Version 2.2017
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Antiemesis address all aspects of management for chemotherapy-induced nausea and vomiting. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for Antiemesis, specifically those regarding carboplatin, granisetron, and olanzapine.
DuckDuckGo
NCCN Guidelines Insights: Antiemesis, Version 2.2017
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Antiemesis address all aspects of management for chemotherapy-induced nausea and vomiting. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for Antiemesis, specifically those regarding carboplatin, granisetron, and olanzapine.
General Meta Tags
81- titleNCCN Guidelines Insights: Antiemesis, Version 2.2017 in: Journal of the National Comprehensive Cancer Network Volume 15 Issue 7 (2017)
- Content-Typetext/html; charset=utf-8
- descriptionThe NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Antiemesis address all aspects of management for chemotherapy-induced nausea and vomiting. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for Antiemesis, specifically those regarding carboplatin, granisetron, and olanzapine.
- article:authorMichael J. Berger
- article:authorDavid S. Ettinger
Open Graph Meta Tags
7- og:urlhttps://jnccn.org/view/journals/jnccn/15/7/article-p883.xml
- og:site_nameJNCCN
- og:typearticle
- og:titleNCCN Guidelines Insights: Antiemesis, Version 2.2017
- og:descriptionThe NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Antiemesis address all aspects of management for chemotherapy-induced nausea and vomiting. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for Antiemesis, specifically those regarding carboplatin, granisetron, and olanzapine.
Twitter Meta Tags
4- twitter:cardsummary_large_image
- twitter:site@jnccn
- twitter:titleNCCN Guidelines Insights: Antiemesis, Version 2.2017
- twitter:descriptionThe NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Antiemesis address all aspects of management for chemotherapy-induced nausea and vomiting. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for Antiemesis, specifically those regarding carboplatin, granisetron, and olanzapine.
Link Tags
15- alternate/newsrss
- canonicalhttps://jnccn.org/view/journals/jnccn/15/7/article-p883.xml
- dns-prefetch//ajax.googleapis.com
- preconnect//ajax.googleapis.com
- preconnect//ajax.googleapis.com
Emails
1- ?subject=Link%20to%20NCCN%20Guidelines%20Insights%3A%20Antiemesis%2C%20Version%202.2017&body=https%3A%2F%2Fjnccn.org%2Fview%2Fjournals%2Fjnccn%2F15%2F7%2Farticle-p883.xml
Links
385- http://education.nccn.org/node/81405
- http://scholar.google.com/scholar_lookup?title=A+comparative+study+of+the+use+of+granisetron%2C+a+selective+5-HT3+antagonist%2C+versus+a+standard+anti-emetic+regimen+of+chlorpromazine+plus+dexamethasone+in+the+treatment+of+cytostatic-induced+emesis.+The+Granisetron+Study+Group&author=M+Marty&publication_year=1990&journal=Eur+J+Cancer&volume=26&issue=Suppl+1&pages=S28-32
- http://scholar.google.com/scholar_lookup?title=A+comparison+of+two+dose+levels+of+granisetron+in+patients+receiving+high-dose+cisplatin.+The+Granisetron+Study+Group&author=M+Soukop&publication_year=1990&journal=Eur+J+Cancer&volume=26&issue=Suppl+1&pages=S15-19
- http://scholar.google.com/scholar_lookup?title=A+double-blind+randomized+phase+II+study+of+10+versus+5+mg+olanzapine+for+emesis+induced+by+highly+emetogenic+chemotherapy+with+cisplatin+%5Babstract%5D&author=H+T+K+Hashimoto+Yanai+Nagashima&publication_year=2016&journal=J+Clin+Oncol&volume=34&issue=Suppl
- http://scholar.google.com/scholar_lookup?title=APF530+%28granisetron+injection+extended-release%29+in+a+three-drug+regimen+for+delayed+CINV+in+highly+emetogenic+chemotherapy&author=ID+R+C+Schnadig+Agajanian+Dakhil&publication_year=2016&journal=Future+Oncol&volume=12&pages=1469-1481